Package 51991-824-33

{"route": ["ORAL"], "spl_id": "fade73fb-a367-4c53-83dd-1352c3ad807b", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0351991822332", "0351991823339", "0351991824336", "0351991821335"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845515", "998189", "1119400", "1308428", "1308430", "1308432"], "spl_set_id": ["01f7b5fb-be0d-4adf-acd2-6899018de966"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (51991-824-28)  / 7 TABLET in 1 BLISTER PACK (51991-824-99)", "package_ndc": "51991-824-28", "marketing_start_date": "20211001"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (51991-824-33)", "package_ndc": "51991-824-33", "marketing_start_date": "20230605"}], "brand_name": "Everolimus", "product_id": "51991-824_fade73fb-a367-4c53-83dd-1352c3ad807b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "51991-824", "generic_name": "Everolimus", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "10 mg/1"}], "application_number": "ANDA205426", "marketing_category": "ANDA", "marketing_start_date": "20210305", "listing_expiration_date": "20261231"}